Influence of particle size and MePEG molecular weight on in vitro macrophage uptake and in vivo long circulating of stealth nanoparticles in rats

Yaoxue Xuebao

Volumn 41, Issue 4, 2006, Pages 305-312

  Fang, Chao ^a,b   Shi, Bin ^b   Hong, Ming Huang ^b   Pei, Yuan Ying ^a,b   Chen, Hong Zhuan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Long circulating; Mononuclear phagocyte system; Nanoparticle; Stealth; Tumor necrosis factor

Indexed keywords

CYANOACRYLATE DERIVATIVE; DRUG CARRIER; MACROGOL DERIVATIVE; MONOMETHOXYPOLYETHYLENE GLYCOL; NANOPARTICLE; POLY (METHOXYPOLYETHYLENEGLYCOL CYANOACRYLATE CO N HEXADECYL CYANOACRYLATE); POLY (METHOXYPOLYETHYLENEGLYCOL CYANOACRYLATE-CO-N-HEXADECYL CYANOACRYLATE); RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECT; MACROPHAGE; MALE; MOLECULAR WEIGHT; MOUSE; PARTICLE SIZE; PHAGOCYTOSIS; PHYSIOLOGY; RANDOMIZATION; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; CYANOACRYLATES; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; MACROPHAGES; MALE; MICE; MOLECULAR WEIGHT; NANOPARTICLES; PARTICLE SIZE; PHAGOCYTOSIS; POLYETHYLENE GLYCOLS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33744936314     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Fang C, Pei YY. Advances in the research of stealth nanoparticles as antitumor drugs carrier [J]. Chin Pharm J 2004, 39:89-92.
2. Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice [J]. Pharmacol Rev, 2001, 53:283-318.
3. Maeda H, Wu J, Sawa T, et al. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review [J]. J Control Release, 2000, 65: 271-284.
4. Li YP, Pei YY, Zhou ZH, et al. Stealth polycyanoacrylate nanoparticles as tumor necrosis factor-alpha carriers: pharmacokinetics and anti-tumor effects [J]. Biol Pharm Bull, 2001, 24:662-665.
5. Brigger I, Dubernet C, Couvreur P. Nanoparticles in cancer therapy and diagnosis [J]. Adv Drug Deliv Rev, 2002, 54:631-651.
6. Fang C, Shi B, Pei YY. Preparation and stability of recombinant human tumor necrosis factor-α-loaded nanoparticles [J]. Acta Pharm Sin, 2004, 39:939-943.
7. Shi B, Fang C, You MX, et al. Stealth PEG-PHDCA niosomes: effects of chain length of PEG on niosoines in vitro complement consumption and phagocytic uptake [J]. Acta Pharm Sin, 2005, 40:976-981.
8. Huang M, Khor E, Lim LY. Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation [J]. Pharm Res. 2004, 21:344-353.
9. Zhang Q, Liao G, Wei DP, et al. Increase in gentamicin uptake by cultured mouse peritoneal macrophages and rat hepatocytes by its binding to polybutylcyanoacrylate nanoparticles [J]. Int J Pharm, 1998, 164:21-27.
10. Peracchia MT, Fattal E, Desmaele D, et al. Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting [J]. J Control Release, 1999, 60:121-128.
11. Mosqueira VC, Legrand P, Morgat JL, et al. Biodistribution of long-circulating PEG-grafted nanocapsules in mice: effects of PEG chain length and density [J]. Pharm Res, 2001, 18:1411-1419.
12. Sadzuka Y, Nakade A, Tsuruda T, et al. Study on the characterization of mixed polyethyleneglycol modified liposomes containing doxorubicin [J]. J Control Release, 2003, 91:271-280.